Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2025-02-05 00:00:00 ET · period of report 2025-02-03 · accession 0001628280-25-004086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-05 | 2025-02-03 | RXRX | Khan Najat | Chief R, D Commercial Off, Dir | F - Tax | $7.25 | -2,753 | 712.4K | -0.4% | -$20.0K |
| DM | 2025-02-05 | 2025-02-03 | RXRX | Khan Najat | Chief R, D Commercial Off, Dir | A - Grant | $0.00 | +218.2K | 715.1K | +44% | $0 |
| D | 2025-02-05 | 2025-02-03 | RXRX | Khan Najat | Chief R, D Commercial Off, Dir | A - Grant | $0.00 | +420.2K | 420.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-02-03 | F | D | 2,753 | $7.25 | 712,381 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-02-03 | A | A | 210,113 | $0.00 | 707,085 | D | — | — | |
| 3 | Common | Class A Common Stock | 2025-02-03 | A | A | 8,049 | $0.00 | 715,134 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-02-03 | A | A | 420,226 | $0.00 | 420,226 | D | $7.25 · — to 2035-02-03 | 420,226 Class A Common Stock | (F4) The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. |